{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:19:41Z","timestamp":1791994781822,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"publisher","award":["Grant # 15145\/15"],"award-info":[{"award-number":["Grant # 15145\/15"]}],"id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12967-016-0823-y","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T20:07:14Z","timestamp":1457467634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells"],"prefix":"10.1186","volume":"14","author":[{"given":"Ahmad","family":"Iskandarani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz A.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodappully S.","family":"Siveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti S.","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Kuttikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzammil A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopesh","family":"Krishnankutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kulinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihab R.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi M.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"823_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425\u201379.","journal-title":"Annu Rev Biochem"},{"key":"823_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.molcel.2005.08.017","volume":"19","author":"M Gao","year":"2005","unstructured":"Gao M, Karin M. Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. Mol Cell. 2005;19:581\u201393.","journal-title":"Mol Cell"},{"key":"823_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrc1881","volume":"6","author":"KI Nakayama","year":"2006","unstructured":"Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer. 2006;6:369\u201381.","journal-title":"Nat Rev Cancer"},{"key":"823_CR4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","volume":"70","author":"CM Pickart","year":"2001","unstructured":"Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503\u201333.","journal-title":"Annu Rev Biochem"},{"key":"823_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/emboj\/19.1.94","volume":"19","author":"JS Thrower","year":"2000","unstructured":"Thrower JS, Hoffman L, Rechsteiner M, Pickart CM. Recognition of the polyubiquitin proteolytic signal. EMBO J. 2000;19:94\u2013102.","journal-title":"EMBO J"},{"key":"823_CR6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbamcr.2013.02.028","volume":"1843","author":"F Bassermann","year":"2014","unstructured":"Bassermann F, Eichner R, Pagano M. The ubiquitin proteasome system\u2014implications for cell cycle control and the targeted treatment of cancer. Biochim Biophys Acta. 2014;1843:150\u201362.","journal-title":"Biochim Biophys Acta"},{"key":"823_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd3321","volume":"10","author":"L Bedford","year":"2011","unstructured":"Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE. Ubiquitin-like protein conjugation and the ubiquitin\u2013proteasome system as drug targets. Nat Rev Drug Discov. 2011;10:29\u201346.","journal-title":"Nat Rev Drug Discov."},{"key":"823_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/12013","volume":"1","author":"AC Carrano","year":"1999","unstructured":"Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999;1:193\u20139.","journal-title":"Nat Cell Biol"},{"key":"823_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/12027","volume":"1","author":"H Sutterluty","year":"1999","unstructured":"Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol. 1999;1:207\u201314.","journal-title":"Nat Cell Biol"},{"key":"823_CR10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0960-9822(99)80290-5","volume":"9","author":"LM Tsvetkov","year":"1999","unstructured":"Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol. 1999;9:661\u20134.","journal-title":"Curr Biol"},{"key":"823_CR11","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/15384101.2015.1056946","volume":"14","author":"A Jamal","year":"2015","unstructured":"Jamal A, Swarnalatha M, Sultana S, Joshi P, Panda SK, Kumar V. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2. Cell Cycle. 2015;14:2688\u2013700.","journal-title":"Cell Cycle"},{"key":"823_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/ERC-06-0030","volume":"14","author":"G Chiappetta","year":"2007","unstructured":"Chiappetta G, De Marco C, Quintiero A, Califano D, Gherardi S, Malanga D, et al. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer. Endocr Relat Cancer. 2007;14:405\u201320.","journal-title":"Endocr Relat Cancer"},{"key":"823_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)63286-5","volume":"165","author":"S Yokoi","year":"2004","unstructured":"Yokoi S, Yasui K, Mori M, Iizasa T, Fujisawa T, Inazawa J. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Am J Pathol. 2004;165:175\u201380.","journal-title":"Am J Pathol"},{"key":"823_CR14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/labinvest.2009.75","volume":"89","author":"S Uddin","year":"2009","unstructured":"Uddin S, Ahmed M, Hussain AR, Jehan Z, Al-Dayel F, Munkarah A, et al. Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer. Lab Invest. 2009;89:1115\u201327.","journal-title":"Lab Invest"},{"key":"823_CR15","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1158\/0008-5472.CAN-07-6109","volume":"68","author":"S Uddin","year":"2008","unstructured":"Uddin S, Ahmed M, Bavi P, El-Sayed R, Al-Sanea N, AbdulJabbar A, et al. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Cancer Res. 2008;68:3379\u201388.","journal-title":"Cancer Res"},{"key":"823_CR16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","volume":"149","author":"CH Chan","year":"2012","unstructured":"Chan CH, Li CF, Yang WL, Gao Y, Lee SW, Feng Z, et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell. 2012;149:1098\u2013111.","journal-title":"Cell"},{"key":"823_CR17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s13277-013-0652-z","volume":"34","author":"YF Tian","year":"2013","unstructured":"Tian YF, Chen TJ, Lin CY, Chen LT, Lin LC, Hsing CH, et al. SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential. Tumour Biol. 2013;34:1107\u201317.","journal-title":"Tumour Biol"},{"key":"823_CR18","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.18632\/oncotarget.2149","volume":"5","author":"J Wang","year":"2014","unstructured":"Wang J, Huang Y, Guan Z, Zhang JL, Su HK, Zhang W, et al. E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma. Oncotarget. 2014;5:5591\u2013601.","journal-title":"Oncotarget."},{"key":"823_CR19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/path.2433","volume":"216","author":"S Uddin","year":"2008","unstructured":"Uddin S, Hussain A, Ahmed M, Belgaumi A, Al-Dayel F, Ajarim D, et al. S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma. J Pathol. 2008;216:483\u201394.","journal-title":"J Pathol."},{"key":"823_CR20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1172\/JCI0215795","volume":"110","author":"S Signoretti","year":"2002","unstructured":"Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest. 2002;110:633\u201341.","journal-title":"J Clin Invest."},{"key":"823_CR21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H","volume":"91","author":"D Hershko","year":"2001","unstructured":"Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, et al. Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer. 2001;91:1745\u201351.","journal-title":"Cancer"},{"key":"823_CR22","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1073\/pnas.081474898","volume":"98","author":"M Gstaiger","year":"2001","unstructured":"Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA. 2001;98:5043\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"823_CR23","first-page":"3419","volume":"8","author":"G Yang","year":"2002","unstructured":"Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler TM, et al. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res. 2002;8:3419\u201326.","journal-title":"Clin Cancer Res"},{"key":"823_CR24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2141.2001.02683.x","volume":"113","author":"D Soligo","year":"2001","unstructured":"Soligo D, Servida F, Delia D, Fontanella E, Lamorte G, Caneva L, et al. The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI. Br J Haematol. 2001;113:126\u201335.","journal-title":"Br J Haematol"},{"key":"823_CR25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/bjc.1998.183","volume":"77","author":"J Delic","year":"1998","unstructured":"Delic J, Masdehors P, Omura S, Cosset JM, Dumont J, Binet JL, et al. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br J Cancer. 1998;77:1103\u20137.","journal-title":"Br J Cancer"},{"key":"823_CR26","first-page":"4342","volume":"58","author":"RZ Orlowski","year":"1998","unstructured":"Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M, Dang CV. Tumor growth inhibition induced in a murine model of human Burkitt\u2019s lymphoma by a proteasome inhibitor. Cancer Res. 1998;58:4342\u20138.","journal-title":"Cancer Res"},{"key":"823_CR27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0093-7754(01)90034-X","volume":"28","author":"J Adams","year":"2001","unstructured":"Adams J. Proteasome inhibition in cancer: development of PS-341. Semin Oncol. 2001;28:613\u20139.","journal-title":"Semin Oncol"},{"key":"823_CR28","first-page":"596","volume":"1","author":"PG Richardson","year":"2003","unstructured":"Richardson PG, Anderson KC. Bortezomib: a novel therapy approved for multiple myeloma. Clin Adv Hematol Oncol. 2003;1:596\u2013600.","journal-title":"Clin Adv Hematol Oncol."},{"key":"823_CR29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10495-006-3392-3","volume":"11","author":"AR Hussain","year":"2006","unstructured":"Hussain AR, Al-Rasheed M, Manogaran PS, Al-Hussein KA, Platanias LC, Al Kuraya K, et al. Curcumin induces apoptosis via inhibition of PI3\u02b9-kinase\/AKT pathway in acute T cell leukemias. Apoptosis. 2006;11:245\u201354.","journal-title":"Apoptosis"},{"key":"823_CR30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.18632\/oncotarget.1596","volume":"5","author":"KS Siveen","year":"2014","unstructured":"Siveen KS, Mustafa N, Li F, Kannaiyan R, Ahn KS, Kumar AP, et al. Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-\u03baB regulated gene products in multiple myeloma xenograft mouse model. Oncotarget. 2014;5:634\u201348.","journal-title":"Oncotarget."},{"key":"823_CR31","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/0008-5472.CAN-06-3764","volume":"67","author":"AR Hussain","year":"2007","unstructured":"Hussain AR, Al-Jomah NA, Siraj AK, Manogaran P, Al-Hussein K, Abubaker J, et al. Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res. 2007;67:3888\u201397.","journal-title":"Cancer Res"},{"key":"823_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1073\/pnas.0307075101","volume":"101","author":"S Uddin","year":"2004","unstructured":"Uddin S, Ah-Kang J, Ulaszek J, Mahmud D, Wickrema A. Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells. Proc Natl Acad Sci USA. 2004;101:147\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"823_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-5793(97)00669-8","volume":"411","author":"S Salvioli","year":"1997","unstructured":"Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 1997;411:77\u201382.","journal-title":"FEBS Lett"},{"key":"823_CR34","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1038\/sj.onc.1208864","volume":"24","author":"S Uddin","year":"2005","unstructured":"Uddin S, Hussain AR, Manogaran PS, Al-Hussein K, Platanias LC, Gutierrez MI, et al. Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene. 2005;24:7022\u201330.","journal-title":"Oncogene"},{"key":"823_CR35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/978-1-61779-998-3_40","volume":"920","author":"A Sharma","year":"2012","unstructured":"Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol. 2012;920:613\u201326.","journal-title":"Methods Mol Biol"},{"key":"823_CR36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/349132a0","volume":"349","author":"M Glotzer","year":"1991","unstructured":"Glotzer M, Murray AW, Kirschner MW. Cyclin is degraded by the ubiquitin pathway. Nature. 1991;349:132\u20138.","journal-title":"Nature"},{"key":"823_CR37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1097-2765(00)80055-6","volume":"1","author":"B Levkau","year":"1998","unstructured":"Levkau B, Koyama H, Raines EW, Clurman BE, Herren B, Orth K, et al. Cleavage of p21Cip1\/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell. 1998;1:553\u201363.","journal-title":"Mol Cell"},{"key":"823_CR38","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1128\/MCB.24.14.6140-6150.2004","volume":"24","author":"P Coulombe","year":"2004","unstructured":"Coulombe P, Rodier G, Bonneil E, Thibault P, Meloche S. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol. 2004;24:6140\u201350.","journal-title":"Mol Cell Biol"},{"key":"823_CR39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7624798","volume":"269","author":"M Pagano","year":"1995","unstructured":"Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, et al. Role of the ubiquitin\u2013proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 1995;269:682\u20135.","journal-title":"Science"},{"key":"823_CR40","first-page":"2615","volume":"59","author":"J Adams","year":"1999","unstructured":"Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 1999;59:2615\u201322.","journal-title":"Cancer Res"},{"key":"823_CR41","first-page":"3071","volume":"61","author":"T Hideshima","year":"2001","unstructured":"Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 2001;61:3071\u20136.","journal-title":"Cancer Res"},{"key":"823_CR42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.cellsig.2004.11.002","volume":"17","author":"F Chen","year":"2005","unstructured":"Chen F, Harrison LE. Ciglitazone-induced cellular anti-proliferation increases p27kip1 protein levels through both increased transcriptional activity and inhibition of proteasome degradation. Cell Signal. 2005;17:809\u201316.","journal-title":"Cell Signal"},{"key":"823_CR43","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1074\/jbc.M312044200","volume":"279","author":"HC Dan","year":"2004","unstructured":"Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG, et al. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem. 2004;279:5405\u201312.","journal-title":"J Biol Chem"},{"key":"823_CR44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/35060126","volume":"3","author":"D Ganoth","year":"2001","unstructured":"Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, et al. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol. 2001;3:321\u20134.","journal-title":"Nat Cell Biol"},{"key":"823_CR45","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/emboj\/19.9.2069","volume":"19","author":"K Nakayama","year":"2000","unstructured":"Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 2000;19:2069\u201381.","journal-title":"EMBO J"},{"key":"823_CR46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/cr.2010.71","volume":"20","author":"L Zhu","year":"2010","unstructured":"Zhu L. Skp2 knockout reduces cell proliferation and mouse body size: and prevents cancer? Cell Res. 2010;20:605\u20137.","journal-title":"Cell Res"},{"key":"823_CR47","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1080\/10428190902951799","volume":"50","author":"AR Hussain","year":"2009","unstructured":"Hussain AR, Ahmed M, Ahmed SO, Al-Thari S, Khan AS, Razack S, et al. Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells. Leuk Lymphoma. 2009;50:1204\u201313.","journal-title":"Leuk Lymphoma"},{"key":"823_CR48","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.1158\/0008-5472.CAN-08-1935","volume":"68","author":"Y Liu","year":"2008","unstructured":"Liu Y, Perdreau SA, Chatterjee P, Wang L, Kuan SF, Duensing A. Imatinib mesylate induces quiescence in gastrointestinal stromal tumor cells through the CDH1-SKP2-p27Kip1 signaling axis. Cancer Res. 2008;68:9015\u201323.","journal-title":"Cancer Res"},{"key":"823_CR49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2184.2009.00662.x","volume":"43","author":"AR Hussain","year":"2010","unstructured":"Hussain AR, Khan AS, Ahmed SO, Ahmed M, Platanias LC, Al-Kuraya KS, et al. Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells. Cell Prolif. 2010;43:170\u201383.","journal-title":"Cell Prolif"},{"key":"823_CR50","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood-2006-11-060350","volume":"110","author":"T Lwin","year":"2007","unstructured":"Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E, et al. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. Blood. 2007;110:1631\u20138.","journal-title":"Blood"},{"key":"823_CR51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hed.1052","volume":"23","author":"BR Gastman","year":"2001","unstructured":"Gastman BR. Apoptosis and its clinical impact. Head Neck. 2001;23:409\u201325.","journal-title":"Head Neck"},{"key":"823_CR52","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1074\/jbc.274.17.11549","volume":"274","author":"H Zou","year":"1999","unstructured":"Zou H, Li Y, Liu X, Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999;274:11549\u201356.","journal-title":"J Biol Chem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-0823-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:56:12Z","timestamp":1498276572000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/14\/1\/69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1186\/s12967-016-0823-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]},"article-number":"69"}}